Beneficial effects of indapamide on lipoproteins and apoproteins in ambulatory hypertensive patients.

@article{Aubert1990BeneficialEO,
  title={Beneficial effects of indapamide on lipoproteins and apoproteins in ambulatory hypertensive patients.},
  author={I. Aubert and F. Djian and J. Rouffy},
  journal={The American journal of cardiology},
  year={1990},
  volume={65 17},
  pages={
          77H-80H
        }
}
Among the numerous risk factors for atherosclerosis, 2 are particularly important: hypertension and primary or secondary abnormalities of plasma lipids and lipoproteins. Antihypertensive treatments significantly decrease the risk of cerebrovascular accidents, renal failure or hypertensive cardiomyopathy, but they have little influence on coronary artery disease. It has been suggested that some antihypertensive agents may have deleterious effects by altering serum lipoproteins and this may… Expand
Antihypertensive therapy and atherosclerosis.
  • M. Horan
  • Medicine
  • The American journal of the medical sciences
  • 1991
Hypertension and atherosclerosis make independent contributions to the pathogenesis of cardiovascular disease. Diuretics and beta adrenergic blockers, effective antihypertensive medications, exhibitExpand
Metabolic Profile of Indapamide Sustained-Release in Patients with Hypertension
AbstractObjective: To evaluate the influence of indapamide sustained-release (SR) 1.5 mg/day, a thiazide-related sulfonamide diuretic, on serum levels of lipids (total cholesterol, high-densityExpand
Not Just Chlorthalidone: Evidence-Based, Single Tablet, Diuretic Alternatives to Hydrochlorothiazide for Hypertension
Accounting for 15 % of deaths worldwide, hypertension is often treated with hydrochlorothiazide (HCTZ) (50 million prescriptions annually). HCTZ has a <24-h duration of action, is less potent thanExpand
Head-to-Head Comparisons of Hydrochlorothiazide With Indapamide and Chlorthalidone: Antihypertensive and Metabolic Effects
Hydrochlorothiazide (HCTZ) has often been contrasted with chlorthalidone, but relatively little is known about HCTZ versus indapamide (INDAP). This systematic review retrieved 9765 publications, andExpand
Head-to-head comparisons of hydrochlorothiazide with indapamide and chlorthalidone: antihypertensive and metabolic effects.
Hydrochlorothiazide (HCTZ) has often been contrasted with chlorthalidone, but relatively little is known about HCTZ versus indapamide (INDAP). This systematic review retrieved 9765 publications, andExpand
A Double‐Blind, Randomized, Placebo‐Controlled Comparison of the Metabolic Effects of Low‐Dose Hydrochlorothiazide and Indapamide
To compare the metabolic effects of indapamide (I) and hydrochlorothiazide (HCTZ) at equivalent hypotensive doses, 11 hypertensive patients (5 male, 8 black, aged 56 ± 8 yr — mean ± SEM) having serumExpand

References

SHOWING 1-10 OF 29 REFERENCES
Effects of antihypertensives on plasma lipids and lipoprotein metabolism.
TLDR
The effects of various antihypertensive drugs on plasma lipids, lipoproteins, and apolipoproteins can be summarized as follows: thiazide-type diuretics cause a marked elevation of plasma triglycerides and very low- density lipoprotein (VLDL) and minor increases in total cholesterol and low-density lipop protein (LDL), but have little effects on high-density cholesterol (HDL). Expand
Serum Lipoprotein Levels During Long‐term Treatment of Hypertension with Indapamide
TLDR
Indapamide is a methylindoline antihypertensive diuretic with a considerable peripheral vasodilatory effect, resulting in a significant fall of the low-density lipoprotein/high-densitylipoprotein ratio, an atherogenic risk factor, regardless of preexisting lipid disorders. Expand
Indapamide. Effects on apoprotein, lipoprotein, and glucoregulation in ambulatory diabetic patients.
We evaluated the long-term effects of indapamide, a non-thiazide diuretic, on blood pressure, glucoregulation, free insulin and C-peptide levels, and lipoprotein and apoprotein metabolism in 13Expand
The effects of antihypertensive agents on serum lipids and lipoproteins.
TLDR
All available antihypertensive medications and their influence on lipoprotein metabolism are reviewed and cost and side effect profiles must also be considered in choosing the best anti Hypertensive regimen for patients. Expand
Mechanism of the interaction of hypertension and hypercholesterolemia in atherogenesis: the effects of antihypertensive agents.
  • V. Dzau
  • Medicine
  • American heart journal
  • 1988
TLDR
The relationship between hypertension and atherosclerosis involves complex mechanisms and selective alpha 1-inhibitors may act at a number of sites on lipoprotein metabolic pathways to favorably influence serum lipids. Expand
Effects of antihypertensive drugs on plasma lipids.
  • H. Nakamura
  • Medicine
  • The American journal of cardiology
  • 1987
TLDR
The prevalence of various types of hyperlipoproteinemia among Japanese is discussed, with special reference to the frequency of atherosclerotic vascular diseases. Expand
Antihypertensive therapy and lipids. Paradoxical influences on cardiovascular disease risk.
TLDR
Since prazosin therapy is least likely to worsen existing risk factors or precipitate their occurrence, it should enhance the benefit of blood pressure reduction in delaying or preventing cardiovascular disease. Expand
The influence of non-beta-blocking drugs on the lipid profile: are diuretics outclassed as initial therapy for hypertension?
  • R. Ames
  • Medicine
  • American heart journal
  • 1987
TLDR
This class of agents, and especially prazosin, has produced the most consistently salutary lipid and metabolic effects and are preferable to diuretics and certain beta blockers with respect to short-term effects on lipids and lipoproteins. Expand
Some wrong-way chemical changes during antihypertensive treatment: comparison of indapamide and related agents.
  • H. Perry
  • Medicine
  • American heart journal
  • 1983
TLDR
Indapamide, a new antihypertensive drug, appears to meet these criteria: it is an effective diuretic with a considerable peripheral vasodilatory effect, and does not appear to induce any significant change in circulating cholesterol. Expand
Serum Lipoproteins During Treatment with the Antihypertensive Agent Indapamide
TLDR
The absence of distinct lipoprotein alterations after short-term indapamide treatment may be of clinical and epidemiological interest. Expand
...
1
2
3
...